Anucleate cell blue assay : a useful tool for identifying novel type II topoisomerase inhibitorsOYAMADA, Yoshihiro; ITO, Hideaki; FUJIMOTO-NAKAMURA, Mika et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 348-350, issn 0066-4804, 3 p.Article

Thanatop : A novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase IIPOLYCARPOU-SCHWARZ, Maria; MÜLLER, Kerstin; DENGER, Stefanie et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4451-4458, issn 0008-5472, 8 p.Article

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIβMARCHION, Douglas C; BICAKU, Elona; TURNER, Joel G et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8467-8475, issn 1078-0432, 9 p.Article

Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cellsMAMIDIPUDI, Vidya; TAO SHI; BRADY, Helen et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 965-976, issn 0344-5704, 12 p.Article

Phytoestrogen genistein as an anti-staphylococcal agentVERDRENGH, Margareta; COLLINS, L. Vincent; BERGIN, Philip et al.Microbes and infection. 2004, Vol 6, Num 1, pp 86-92, issn 1286-4579, 7 p.Article

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole classMANI, Nagraj; GROSS, Christian H; GROSSMAN, Trudy H et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1228-1237, issn 0066-4804, 10 p.Article

Inhibition of glutathione synthesis overcomes bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-lndependent pathwayYOSHIDA, Akira; TAKEMURA, Haruyuki; INOUE, Hitoshi et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5772-5780, issn 0008-5472, 9 p.Article

A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cellsPATRA, Nabanita; DE, Umasankar; KANG, Jin-Ah et al.European journal of pharmacology. 2011, Vol 658, Num 2-3, pp 98-107, issn 0014-2999, 10 p.Article

Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-MycBIDWELL, Gene L; RANCHER, Drazen.Biochemical pharmacology. 2005, Vol 71, Num 3, pp 248-256, issn 0006-2952, 9 p.Article

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo EfficacyDOUGHERTY, Thomas J; NAYAR, Asha; NEWMAN, Joseph V et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2657-2664, issn 0066-4804, 8 p.Article

Dietary Influences on Mutagenesis—Where is This Field Going?FERGUSON, Lynnette R.Environmental and molecular mutagenesis (Print). 2010, Vol 51, Num 8-9, pp 909-918, issn 0893-6692, 10 p.Article

The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabineWALSBY, Elisabeth J; COLES, Steven J; KNAPPER, Steven et al.Haematologica (Roma). 2011, Vol 96, Num 3, pp 393-399, issn 0390-6078, 7 p.Article

Interaction between double helix DNA fragments and the new antitumor agent sabarubicin, Men10755MAZZINI, Stefania; SCAGLIONI, Leonardo; ANIMATI, Fabio et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 4, pp 1497-1506, issn 0968-0896, 10 p.Article

Targeted Cancer Therapy with a 2-Deoxyglucose―Based Adriamycin ComplexJIE CAO; SISI CUI; SIWEN LI et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 4, pp 1362-1373, issn 0008-5472, 12 p.Article

Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicityLI JING; YINGLIANG WU; JING WU et al.European journal of pharmacology. 2011, Vol 659, Num 2-3, pp 224-232, issn 0014-2999, 9 p.Article

Type IIA topoisomerase inhibition by a new class of antibacterial agentsBAX, Benjamin D; CHAN, Pan F; JIANZHONG HUANG et al.Nature (London). 2010, Vol 466, Num 7309, pp 935-940, issn 0028-0836, 6 p.Article

Tumor Cells Upregulate Normoxic HIF-1α in Response to DoxorubicinYITING CAO; EBLE, Joseph M; DEWHIRST, Mark W et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 20, pp 6230-6242, issn 0008-5472, 13 p.Article

Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicityDEMIRKAYA, Erkan; AVCI, Aslihan; KESIK, Vural et al.Canadian journal of physiology and pharmacology. 2009, Vol 87, Num 8, pp 633-640, issn 0008-4212, 8 p.Article

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 InhibitionTURNER, Joel G; MARCHION, Douglas C; DAWSON, Jana L et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 17, pp 6899-6905, issn 0008-5472, 7 p.Article

Aldo-Keto Reductase 1C2 Fails to Metabolize Doxorubicin and Daunorubicin in VitroTAKAHASHI, Ryan H; BAINS, Onkar S; PFEIFER, Tom A et al.Drug metabolism and disposition. 2008, Vol 36, Num 6, pp 991-994, issn 0090-9556, 4 p.Article

Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virusTING WU; YAN WANG; YAN YUAN et al.Antiviral research. 2014, Vol 107, pp 95-101, issn 0166-3542, 7 p.Article

Enhancing the Antitumor Activity of Adriamycin and Ionizing RadiationWENQING SUN; KALEN, Amanda L; SMITH, Brian J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4294-4300, issn 0008-5472, 7 p.Article

Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal DoxorubicinPASTORINO, Fabio; DI PAOLO, Daniela; MARIMPIETRI, Danilo et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7320-7329, issn 1078-0432, 10 p.Article

Lunacridine from Lunasia amara is a DNA intercalating topoisomerase II inhibitorPRESCOTT, Thomas A. K; SADLER, Ian H; KIAPRANIS, Robert et al.Journal of ethnopharmacology. 2007, Vol 109, Num 2, pp 289-294, issn 0378-8741, 6 p.Article

Schisandrin B Prevents Doxorubicin-Induced Cardiotoxicity via Enhancing Glutathione Redox CyclingLING LI; QIANGRONG PAN; WEIDONG HAN et al.LING LI; Clinical cancer research. 2007, Vol 13, Num 22, pp 6753-6760, issn 1078-0432, 8 p., 1Article